Smith & Nephew plc (LON:SN) hit a new 52-week high during trading on Friday . The company traded as high as GBX 1,442 ($19.03) and last traded at GBX 1,428 ($18.84), with a volume of 1,929,231 shares trading hands. The stock had previously closed at GBX 1,431 ($18.88).
Several research analysts recently weighed in on SN shares. Credit Suisse Group reaffirmed a “neutral” rating and issued a GBX 1,280 ($16.89) target price on shares of Smith & Nephew plc in a research report on Friday, July 28th. Citigroup Inc. reissued a “sell” rating and issued a GBX 1,160 ($15.31) price objective on shares of Smith & Nephew plc in a research report on Monday, July 10th. Berenberg Bank reissued a “hold” rating and issued a GBX 1,300 ($17.15) price objective on shares of Smith & Nephew plc in a research report on Tuesday, July 18th. Deutsche Bank AG reissued a “buy” rating on shares of Smith & Nephew plc in a research report on Friday, October 13th. Finally, Jefferies Group LLC reissued a “buy” rating and issued a GBX 1,515 ($19.99) price objective on shares of Smith & Nephew plc in a research report on Thursday, October 12th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of GBX 1,300.58 ($17.16).
The firm’s 50 day moving average price is GBX 1,376.89 and its 200-day moving average price is GBX 1,341.14. The firm’s market cap is GBX 12.50 billion.
In related news, insider Virginia Bottomley purchased 223 shares of the firm’s stock in a transaction dated Wednesday, August 16th. The shares were acquired at an average cost of GBX 1,380 ($18.21) per share, with a total value of £3,077.40 ($4,060.97).
ILLEGAL ACTIVITY NOTICE: This story was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2017/10/27/smith-nephew-plc-sn-hits-new-1-year-high-at-1442-00.html.
About Smith & Nephew plc
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with MarketBeat.com's FREE daily email newsletter.